Trial intelligence / Profile preview

24-week open-label study of rivastigmine patch with 1-step titration in mild to moderate Alzheimer's disease patients switched from other cholinesterase inhibitors

jRCT1080223175Phase 4Completed

Sponsor

Novartis

Start

Apr 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1